Contract facts
8APROGRAM PLANNING AND MANAGEMENT is a federal 8A award for Fda Office Of Acq Grant Svcs held by Versatech, Inc. Estimated value $341K ($341K obligated). Current period of performance ends Sep 26, 2023. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.
Recompete timing
PublicCurrent PoP ended Sep 26, 2023 (1060 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordVersatech, Inc — $7.3M obligated across 27 awards (firm-wide, all agencies) · lead buyer Department of Justice (DOJ).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75F40122F80441?
75F40122F80441 (Program planning and management) is a Fda Office Of Acq Grant Svcs award with a potential value of $341K, currently held by Versatech, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75F40122F80441?
Fda Office Of Acq Grant Svcs awarded 75F40122F80441 to Versatech, Inc (potential $341K).
Who is the incumbent on 75F40122F80441?
Versatech, Inc is the incumbent with $7.3M across 27 related awards in SCOUT’s public footprint. The current period of performance ends Sep 26, 2023.
When does Versatech, Inc’s 75F40122F80441 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 26, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
